General discussion 9 293 53. Bosman L, Hoek, R. van den, Waarden, W. van, Knottnerus, B., Hek, K., Berends, M., Chu, C., Homburg, M., Dijk, L. van, Berger, M., Bij, S. van der, Olde Hartman, T., Muris, J., Peters, L., Verheij, R., Bos, I. Het Post-COVID-syndroom: hoe definiëren we het en hoe vaak komt het voor? Utrecht: Nivel, 2022 16 May 2022. 54. Nivel. Post-COVID-syndroom: aanhoudende klachten na COVID-19 en de ‘zorgpaden’ van patiënten: een mixed-method benadering, 2021-2022. Available at: https://www.nivel.nl/nl/ project/post-covid-syndroom-aanhoudende-klachten-na-covid-19-en-de-zorgpaden-vanpatienten-een. 55. Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. The Lancet 2022; 400(10350): 452-61. 56. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239-42. 57. RIVM. Resultaten. Available at: https://www.rivm.nl/pienter-corona-onderzoek/resultaten. Accessed 12 June 2023. 58. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021; 594(7862): 259-64. 59. Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nature Reviews Cardiology 2023. 60. Douaud GA-OX, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. (1476-4687 (Electronic)). 61. ZonMw. VeCosCO:Neurobiologische basis van langdurige cognitieve klachten en vermoeidheid na COVID-19. Available at: https://projecten.zonmw.nl/nl/project/vecosconeurobiologischebasis-van-langdurige-cognitieve-klachten-en-vermoeidheid-na-covid. Accessed 22 May 62. Lopez-Leon SA-O, Wegman-Ostrosky TA-O, Perelman CA-O, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. (2045-2322 (Electronic)). 63. Huang Q, Jia M, Sun Y, et al. One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis. Value in Health 2022. 64. Tran V-T, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nature Communications 2022; 13(1): 1812. 65. Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nature Communications 2021; 12(1): 6571. 66. Hastie CE, Lowe DJ, McAuley A, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nature Communications 2022; 13(1): 5663. 67. Hodgson CL, Higgins AM, Bailey MJ, et al. Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness. American Journal of Respiratory and Critical Care Medicine 2022; 205(10): 1159-68. 68. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nature Medicine 2021; 27(4): 601-15. 69. Saccon TD, Mousovich-Neto F, Ludwig RG, et al. SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner. Nature Communications 2022; 13(1): 5722. 70. Florencio LL, Fernández-de-las-Peñas C. Long COVID: systemic inflammation and obesity as therapeutic targets. The Lancet Respiratory Medicine 2022; 10(8): 726-7.
RkJQdWJsaXNoZXIy MTk4NDMw